Continued Opioid Use and Adverse Events Following Provision of Opioids for Musculoskeletal Pain in the Emergency Department: A Systematic Review and Meta-Analysis.

Autor:	Chen, Qiuzhe, Maher, Chris G., Han, Christopher S., Abdel Shaheed, Christina, Lin, Chung-Wei Christine, Rogan, Eileen M., Machado, Gustavo C.
Předmět:	CINAHL database HOSPITAL emergency services META-analysis MEDICAL information storage & retrieval systems CONFIDENCE intervals SYSTEMATIC reviews MUSCULOSKELETAL pain DISEASE prevalence QUALITY assurance DESCRIPTIVE statistics RESEARCH funding OPIOID analgesics DRUG side effects MEDLINE
Zdroj:	Drugs; Nov2023, Vol. 83 Issue 16, p1523-1535, 13p
Abstrakt:	Background: The prevalence of continued opioid use or serious adverse events (SAEs) following opioid therapy in the emergency department (ED) for musculoskeletal pain is unclear. The aim of this review was to examine the prevalence of continued opioid use and serious adverse events (SAEs) following the provision of opioids for musculoskeletal pain in the emergency department (ED) or at discharge. Methods: Records were searched from MEDLINE, EMBASE and CINAHL from inception to 7 October 2022. We included randomised controlled trials and observational studies enrolling adult patients with musculoskeletal pain who were administered and/or prescribed opioids in the ED. Continued opioid use and opioid misuse data after day 4 since ED discharge were extracted. Adverse events were coded using the Common Terminology Criteria for Adverse Events (CTCAE), and those rated as grades 3–4 (severe or life-threatening) and grade 5 (death) were considered SAEs. Risk of bias was assessed using the Quality in Prognosis Studies (QUIPS) tool. Results: Seventy-two studies were included. Among opioid-naïve patients who received an opioid prescription, 6.8–7.0% reported recent opioid use at 3–12 months after discharge, 4.4% filled ≥ 5 opioid prescriptions and 3.1% filled > 90-day supply of opioids within 6 months. The prevalence of SAEs was 0.02% [95% confidence interval (CI) 0, 0.2%] in the ED and 0.1% (95% CI 0, 1.5%) within 2 days. One study observed 42.9% of patients misused opioids within 30 days after discharge. Conclusions: Around 7% of opioid-naïve patients with musculoskeletal pain receiving opioid therapy continue opioid use at 3–12 months after ED discharge. SAEs following ED administration of an opioid were uncommon; however, studies only monitored patients for 2 days. Protocol Registration: 10.31219/osf.io/w4z3u. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink